Scientific Advisory Board

Omer Kucuk, MD, FACN
Dr. Omer Kucuk is a Professor of Hematology and Medical Oncology and Professor of Urology at the Emory University School of Medicine (Atlanta, GA).
David Graham, MD
David is a Medical Oncologist at the Levine Cancer Institute and has obtained his Medical Degree from Mayo Medical School. He has been in practice for 28 years.
David Alberts, MD
David S. Alberts, M.D., is Director Emeritus of the University of Arizona Cancer Center (UACC), and Regents Professor of Medicine, Pharmacology, Public Health and Nutritional Sciences.
David Kwok, B.SC. (PHARM), M.SC., PhD.
David Kwok is the founder and President of BRI Biopharmaceutical Research Inc.
Abbas Mohammed Ghawi, PhD.
Dr. Abbas has a PhD from Brisbane University, Australia, in pathology and more than 30 years of experience in academia and private consulting.
Nayaz Ahmed, PhD.
Dr. Ahmed is a pharmaceutical development scientist experienced in R&D, regulatory compliance and quality control.
Gary Yalloway, PhD
Director, Executive Vice President and Chief Operating Officer
Dr. Yalloway has over 22 years of multidisciplinary research experience and skills in enzyme engineering, protein purification, and structural functional relationships of proteins of medical and industrial interest.
Mohammed DH Hassona, RPH, PhD
Mohammed DH Hassona, RPH, PhD
Board Member
Dr. Mohamed DH Hassona received his PhD degree from The Ohio State University, USA. He has more than 10 years’ experience in preclinical and translational research in pharmacology and molecular biology.
Yuzhuo Wang, B.SC, M.SC., PhD., PDF
Dr. Yuzhuo Wang has a dual appointment as a Senior Scientist at Vancouver Prostate Centre and BC Cancer Agency.